Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

Hyde, C., Wake, B., Bryan, S., Barton, P. M., Fry-Smith, A., Davenport, C. and Song, F. (2002) Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technology Assessment, 6 (2). pp. 1-89. ISSN 2046-4924

Full text not available from this repository.
Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care
Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health
Faculty of Medicine and Health Sciences > Research Centres > Population Health (former - to 2025)
Depositing User: EPrints Services
Date Deposited: 25 Nov 2010 11:10
Last Modified: 16 Jun 2026 13:47
URI: https://uea-test-2026.eprints-hosting.org/id/eprint/12946
DOI: 10.3310/hta6020

Actions (login required)

View Item View Item